Evaluation of Permanent Damages Related to The Virus in Young Adults After the Covıd-19 Pandemic





COVID 19, Coronavirus, Pandemic, Health


Aim: The aim of this study is to evaluate the mid- and long-term health effects of the COVID-19 virus and the COVID-19 vaccine on individuals after the COVID-19 pandemic. Material and Methods: The research was conducted with young adults studying at a university in Turkey. A total of 468 individuals between the ages of 18-40, without any chronic illnesses, and willing to participate in the study were included. Research data were collected through a questionnaire, and the data were analyzed using SPSS (25th version). Results: The average age of the participants was 21.00 ± 2.74 years, 63.5% were male, and 100% had no chronic illnesses before the COVID-19 pandemic. All participants (100%) received the COVID-19 vaccine, with 68.6% preferring the BioNTech vaccine. Of the participants, 28.4% had experienced COVID-19, and 2.6% reported ongoing side effects related to the vaccine. After the COVID-19 pandemic, 1.7% of participants experienced hypertension, 2.2% had conditions related to diabetes, and 1.9% reported persistent cough. Conclusion: The data obtained from the study suggest the occurrence of different health problems related to the COVID-19 virus and vaccination among participants. It is concluded that these effects may be associated with COVID-19, and further data are needed for the assessment of effects related to COVID-19 vaccines.


Abukhalil, A. D., Shatat, S. S., Abushehadeh, R. R., Al-Shami, N. m., Naseef, H. A., & Rabba, A. (2023). Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community. BMC Infectious Diseases, 23(1), 5.

Adamczak, M., Surma, S., & Więcek, A. (2022). Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment. Advances in Clinical and Experimental Medicine, 31(3), 317-326.

Akarsu, G. D. (2022). Determining the health problems experienced by young adults in Turkey, who received the COVID-19 vaccine. Vaccines, 10(9), 1526.

Aldali, H. J., Aldali, J. A., Alotaibi, B. A., Alasiri, G. A., Alromih, A. M., Elsokkary, E. M., Aldali, A. Z., & Almeziny, A. (2023). Evaluating the Adverse Events Associated with Three Doses of the COVID-19 Vaccination in Adults in the Western Region of Saudi Arabia: A Cross-Sectional Study. Vaccines, 11(2), 266.

Amodio, D., Pascucci, G. R., Cotugno, N., Rossetti, C., Manno, E. C., Pighi, C., Morrocchi, E., D'Alessandro, A., Perrone, M. A., & Valentini, A. (2023). Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children. Clinical Immunology, 255, 109751.

Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020). The COVID-19 pandemic. Critical reviews in clinical laboratory sciences, 57(6), 365-388.

Davies, N. G., Klepac, P., Liu, Y., Prem, K., Jit, M., & Eggo, R. M. (2020). Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature medicine, 26(8), 1205-1211.

Demir, O., Sal, H., & Comba, C. (2021). Triangle of COVID, anxiety and menstrual cycle. Journal of Obstetrics and Gynaecology, 41(8), 1257-1261.

Duque, J. S. R., Leung, D., Yip, K. M., Lee, D. H., So, H.-k., Wong, W. H., & Lau, Y. L. (2023). COVID-19 vaccines versus pediatric hospitalization. Cell Reports Medicine, 4(2).

El‐Battrawy, I., Nuñez‐Gil, I. J., Abumayyaleh, M., Estrada, V., Manuel Becerra‐Muñoz, V., Uribarri, A., Fernández‐Rozas, I., Feltes, G., Arroyo‐Espliguero, R., & Trabattoni, D. (2021). COVID‐19 and the impact of arterial hypertension—An analysis of the international HOPE COVID‐19 Registry (Italy‐Spain‐Germany). European Journal of Clinical Investigation, 51(11), e13582.

Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper Jr, L. T. (2023). COVID-19, myocarditis and pericarditis. Circulation research, 132(10), 1302-1319.

García-Vicente, P., Rodríguez-Valiente, A., Górriz Gil, C., Márquez Altemir, R., Martínez-Pérez, F., López-Pajaro, L. F., & García-Berrocal, J. R. (2023). Chronic cough in post-COVID syndrome: Laryngeal electromyography findings in vagus nerve neuropathy. PloS one, 18(3), e0283758.

Giubilini, A., Savulescu, J., & Wilkinson, D. (2020). COVID-19 vaccine: vaccinate the young to protect the old? Journal of Law and the Biosciences, 7(1), lsaa050.

Hasdemir, P. S., Senol Akar, S., Goker, A., Kosova, F., Ucar, D., Ozalp Ates, F. S., & Akcali, S. (2023). The effect of COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels in reproductive age women. Human Fertility, 26(1), 153-161.

Hosseini, R., & Askari, N. (2023). A review of neurological side effects of COVID-19 vaccination. European Journal of Medical Research, 28(1), 1-8.

Husted, M., Gibbons, A., Cheung, W.-Y., & Keating, S. (2023). COVID-19 vaccination hesitancy in adults in the United Kingdom: Barriers and facilitators to uptake. Health Psychology.

Jothimani, D., Venugopal, R., Abedin, M. F., Kaliamoorthy, I., & Rela, M. (2020). COVID-19 and the liver. Journal of hepatology, 73(5), 1231-1240.

Kai, X., Xiao-Yan, T., Miao, L., Liang, Z.-W., Jiang-Nan, C., Jiao-Jiao, L., Jiang, L.-G., Fu-Qiang, X., & Jiang, Y. (2021). Efficacy and safety of COVID-19 vaccines: a systematic review. Chinese Journal of Contemporary Pediatrics, 23(3), 221.

Khan, F., Khan, M. T., Zaman, S., Mujtaba, S., Batool, A., Ghanghro, Z., Anwar, A., & Hashmi, A. A. (2023). Side effects of COVID-19 vaccines among diabetic subjects and healthy individuals. Cureus, 15(3).

Komici, K., Verderosa, S., D’Amico, F., & Guerra, G. (2023). Self-reported side effects following COVID-19 vaccination in athletes: a retrospective study. Human Vaccines & Immunotherapeutics, 19(2), 2234788.

Lam, J. N., Nehira, J., Phung, O., & Deng, B. (2023). Systematic Review: Safety and Efficacy of mRNA COVID-19 Vaccines in Pregnant Women. Journal of Pharmacy Practice, 08971900231196065.

Lee, C. Y., & Suzuki, J. B. (2023). COVID-19: variants, immunity, and therapeutics for non-hospitalized patients. Biomedicines, 11(7), 2055.

Matsumoto, C., Shibata, S., Kishi, T., Morimoto, S., Mogi, M., Yamamoto, K., Kobayashi, K., Tanaka, M., Asayama, K., & Yamamoto, E. (2023). Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertension Research, 46(3), 601-619.

Mitze, T., Kosfeld, R., Rode, J., & Wälde, K. (2020). Face masks considerably reduce COVID-19 cases in Germany. Proceedings of the National Academy of Sciences, 117(51), 32293-32301.

Muller, I., Consonni, D., Crivicich, E., Di Marco, F., Currò, N., & Salvi, M. (2023). Increased risk of Thyroid Eye Disease following Covid-19 Vaccination. The Journal of Clinical Endocrinology & Metabolism, dgad501.

Munjal, J. S., Flores, S. M., Yousuf, H., Gupta, V., Munjal, R. S., Anamika, F., Mendpara, V., Shah, P., & Jain, R. (2023). Covid-19 Vaccine-induced Myocarditis. Journal of Community Hospital Internal Medicine Perspectives, 13(5), 44.

Niebel, D., Novak, N., Wilhelmi, J., Ziob, J., Wilsmann-Theis, D., Bieber, T., Wenzel, J., & Braegelmann, C. (2021). Cutaneous adverse reactions to COVID-19 vaccines: insights from an immuno-dermatological perspective. Vaccines, 9(9), 944.

Nogueira-de-Almeida, C. A., Del Ciampo, L. A., Ferraz, I. S., Del Ciampo, I. R., Contini, A. A., & Ued, F. d. V. (2020). COVID-19 and obesity in childhood and adolescence: a clinical review. Jornal de pediatria, 96, 546-558.

Notarte, K. I., Catahay, J. A., Velasco, J. V., Pastrana, A., Ver, A. T., Pangilinan, F. C., Peligro, P. J., Casimiro, M., Guerrero, J. J., & Gellaco, M. M. L. (2022). Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine, 53.

Offit, P. A. (2023). COVID-19 Vaccines in Young Children—Reassuring Evidence for Parents. JAMA pediatrics, 177(4), 333-334.

Paul, P., El-Naas, A., Hamad, O., Salameh, M. A., Mhaimeed, N., Laswi, I., Abdelati, A. A., AlAnni, J., Khanjar, B., & Al-Ali, D. (2023). Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review. Human Vaccines & Immunotherapeutics, 19(1), 2167410.

Rivera-Torres, J., Girón, N., & San José, E. (2023). COVID-19: A Comprehensive Review on Cardiovascular Alterations, Immunity, and Therapeutics in Older Adults. Journal of Clinical Medicine, 12(2), 488.

Rzymski, P., Kasianchuk, N., Sikora, D., & Poniedziałek, B. (2023). COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022. Journal of Medical Virology, 95(1), e28131.

Silva, T. C., Anghinoni, L., Chagas, C. P. d., Zhao, L., & Tabak, B. M. (2023). Analysis of the Effectiveness of Public Health Measures on COVID-19 Transmission. International Journal of Environmental Research and Public Health, 20(18), 6758.

Wang, L., Li, X., Chen, H., Yan, S., Li, D., Li, Y., & Gong, Z. (2020). Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China. American journal of nephrology, 51(5), 343-348.

Yaamika, H., Muralidas, D., & Elumalai, K. (2023). Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases. Journal of Taibah University Medical Sciences.




How to Cite

Akarsu, G. D. (2023). Evaluation of Permanent Damages Related to The Virus in Young Adults After the Covıd-19 Pandemic. Mediterian Journal of Health Sciences Current Research, 1(1), 1–10. https://doi.org/10.5281/zenodo.10446726